Posted on Friday, May 16, 2014 at 12:08 pm CDT
The Gastric Cancer Partnering 2009-2014 provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 12:01 pm CDT
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 11:51 am CDT
Diphtheria - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 11:37 am CDT
Lupus Nephritis - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 11:22 am CDT
Genor BioPharma Co., Ltd. - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 11:08 am CDT
GlobalData's clinical trial report, "Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Foot Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Foot Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Foot Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 11:06 am CDT
Lysosomal Storage Disorder - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 11:04 am CDT
Post Menopausal Osteoporosis - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 10:49 am CDT
Partial Seizure - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 10:22 am CDT
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:49 am CDT
Tillotts Pharma AG - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:47 am CDT
Burkitt Lymphoma - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:35 am CDT
Innopharmax Inc. - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:24 am CDT
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:21 am CDT
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:11 am CDT
Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Friday, May 16, 2014 at 9:00 am CDT
GlobalData's clinical trial report, "Supratentorial Glioma Global Clinical Trials Review, H1, 2014" provides data on the Supratentorial Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Supratentorial Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Supratentorial Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 2:56 pm CDT
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 2:24 pm CDT
Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 2:20 pm CDT
MI.TO. Technology S.r.L. - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 2:12 pm CDT
Genital Herpes - Pipeline Review, H1 2014
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 1:58 pm CDT
The Menopause Partnering 2009-2014 report provides understanding and access to the menopause partnering deals and agreements entered into by the worlds leading healthcare companies.
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 1:34 pm CDT
The Osteoarthritis Partnering 2009-2014 report provides understanding and access to the osteoarthritis partnering deals and agreements entered into by the worlds leading healthcare companies.
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 1:34 pm CDT
Activaero GmbH - Product Pipeline Review - 2014
Source: Fast Market Research
Posted on Thursday, May 15, 2014 at 1:31 pm CDT
Diabetic Retinopathy - Pipeline Review, H1 2014
Source: Fast Market Research